Nkcfo LLC Sells 3,700 Shares of Teradyne, Inc. $TER

Key Points

• Sold 3,700 shares: Nkcfo LLC reduced its stake in Teradyne by 20% in the 4th quarter, holding 14,800 shares valued at about $2.865 million after the sale, per its SEC filing.
• Analyst momentum: Several firms have upgraded TER (notably JPMorgan to Overweight with a $400 target), leaving a consensus of "Moderate Buy" with an average price target of $339.80 (11 Buys, 5 Holds).
• Mixed fundamentals and reaction: Teradyne reported a strong Q1 (EPS $2.56 vs. $2.11, revenue $1.28B, +87% YoY) but gave softer Q2 guidance that spurred a selloff before the stock later rebounded (trading up ~12.1%, market cap ~$53.8B).

Nkcfo LLC lowered its holdings in Teradyne, Inc. (NASDAQ:TER - Free Report) by 20.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,800 shares of the company's stock after selling 3,700 shares during the period. Nkcfo LLC's holdings in Teradyne were worth $2,865,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Root Financial Partners LLC purchased a new position in Teradyne in the third quarter valued at about $31,000. Davidson Capital Management Inc. bought a new position in shares of Teradyne in the third quarter worth $31,000. CYBER HORNET ETFs LLC bought a new position in Teradyne in the 2nd quarter worth about $35,000. Hemington Wealth Management boosted its position in shares of Teradyne by 43.2% in the third quarter. Hemington Wealth Management now owns 262 shares of the company's stock valued at $36,000 after acquiring an additional 79 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of Teradyne during the 4th quarter valued at $37,000. Institutional investors own 99.77% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on TER. JPMorgan Chase & Co. raised Teradyne from a "neutral" rating to an "overweight" rating and set a $400.00 price objective for the company in a report on Thursday. Stifel Nicolaus raised their price objective on Teradyne from $325.00 to $390.00 and gave the company a "buy" rating in a research note on Tuesday. Royal Bank Of Canada set a $270.00 price objective on Teradyne in a report on Monday, February 2nd. Susquehanna increased their target price on Teradyne from $335.00 to $415.00 and gave the company a "positive" rating in a report on Thursday, April 9th. Finally, Wall Street Zen raised Teradyne from a "hold" rating to a "buy" rating in a research note on Saturday, February 21st. Eleven analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $339.80.

Teradyne News Roundup

Here are the key news stories impacting Teradyne this week:

• Positive Sentiment: JPMorgan upgraded TER from Neutral to Overweight and set a $400 price target, calling the post-earnings pullback an attractive entry—this upgrade is a clear catalyst lifting the stock. JPMorgan upgrade article
• Positive Sentiment: Teradyne was added to Zacks’ Rank #1 (Strong Buy) momentum list, which can attract momentum and quant flows into the name. Zacks momentum article
• Positive Sentiment: Unusual options activity—6,641 calls traded (about +16% vs. average)—signals speculative/hedged bullish positioning by traders that can amplify upside on positive headlines. Options activity report
• Neutral Sentiment: A brokerage consensus piece cites a $324.53 target for TER—useful context for analyst expectations but mixed given targets vary widely post-earnings. Brokerage target article
• Negative Sentiment: Teradyne’s Q2 guidance ($1.15B–$1.25B revenue) and management’s model (longer-term $6B revenue / $9.50–$11 EPS framework) disappointed investors relative to lofty expectations, triggering the initial selloff after otherwise strong Q1 results. Q2 guidance article
• Negative Sentiment: Despite a blowout Q1 (record revenue, EPS beat), shares plunged as investors framed the move as an “expectations issue”—Morgan Stanley flagged a tempered AI networking outlook, reinforcing caution. Morgan Stanley note
• Negative Sentiment: Coverage and headlines emphasizing the post-earnings 15–20% pullback kept momentum weak until fresh analyst upgrades and option flows improved sentiment. Selloff coverage

Teradyne Trading Up 12.1%

TER stock opened at $343.47 on Friday. The stock has a market capitalization of $53.77 billion, a price-to-earnings ratio of 63.61, a PEG ratio of 1.77 and a beta of 1.79. The firm's 50-day moving average price is $329.08 and its two-hundred day moving average price is $249.02. Teradyne, Inc. has a 12-month low of $73.11 and a 12-month high of $422.11.

Teradyne (NASDAQ:TER - Get Free Report) last posted its earnings results on Tuesday, April 28th. The company reported $2.56 earnings per share for the quarter, topping analysts' consensus estimates of $2.11 by $0.45. The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.20 billion. Teradyne had a net margin of 22.55% and a return on equity of 31.79%. Teradyne's revenue for the quarter was up 87.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.75 earnings per share. Teradyne has set its Q2 2026 guidance at 1.860-2.150 EPS. Equities analysts predict that Teradyne, Inc. will post 6.33 EPS for the current year.

About Teradyne

Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.

The company's product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.